Has Moufid Abdo, MD received payments from drug or device companies?

Yes. Drug and device makers reported $2,075 in general payments to Moufid Abdo, MD across 28 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Moufid Abdo, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Moufid Abdo, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Moufid Abdo, MD

Otolaryngology · Sarasota, FLNPI 1568463347

Payments from drug & device makers

$2,075in general payments, 2019–2025

Across 28 payments — averaging $74.10 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Medical Device Business Services, Inc.$2K
Acclarent, Inc$263
Optinose US, Inc.$80
Stryker$36
Regeneron Healthcare Solutions, Inc.$18

What the payments were for

Travel & lodging$1,47071%
Food & beverage$60529%

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Medical Device Business Services, Inc.	10	$1,679
Acclarent, Inc	10	$263
Optinose US, Inc.	5	$80
Stryker	2	$36
Regeneron Healthcare Solutions, Inc.	1	$18

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$2,075 in reported general payments places this provider in the 55th percentile of 586 otolaryngology providers in Florida.

See all otolaryngology providers in Florida →

Medicare billing

Part B allowed, 2024

$114,660

Medicare patients

511

Services billed

1,510

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
Ipratropium Bromide	89	$2,985
Famotidine	201	$2,252
Azelastine Hcl	64	$2,145
Dexamethasone	31	$1,021
Omeprazole	86	$917
Fluticasone Propionate	66	$899
Fluocinolone Acetonide Oil	16	$476
Levocetirizine Dihydrochloride	13	$474
Pantoprazole Sodium	22	$244
Tramadol Hcl	12	$181
Prednisone	17	$123
Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav	12	$118

Paid to pharmacies, not to this prescriber.

Other otolaryngology in Sarasota

Ralph TufanoSarasota$733K
Craig ShapiroHollywood$8.1M
Adrien EshraghiMiami$2.1M
Cecelia DamaskOrlando$771K
Mitchell MillerClearwater$709K
Brian KerrGainesville$629K
Maria SuurnaMiami$456K
Mark TaborTampa$348K
Franklin RimellFort Myers$314K
Tapan PadhyaTampa$314K

See the full list for Florida →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →